Scolaris Content Display Scolaris Content Display

Exercise or exercise and diet for preventing type 2 diabetes mellitus

Esta versión no es la más reciente

Contraer todo Desplegar todo

Referencias

Bo 2007 {published data only}

Bo S, Ciccone G, Baldi C, Benini L, Dusio F, Forastiere G, et al. Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial. Journal of General Internal Medicine 2007;22(12):1695‐703.

Da Qing 1997 {published data only}

Li GW, Hu YH, Yang WY, Jiang YY, Wang JP, Xiao JZ, et al. Effects of insulin resistance and insulin secretion on the efficacy of interventions to retard development of type 2 diabetes mellitus: the Da Qing IGT and Diabetes Study. Diabetes Research and Clinical Practice 2002;58:193‐200.
Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance.The Da Qing IGT and diabetes study. Diabetes Care 1997;20:537‐44.

DPP 2002 {published data only}

Crandall J, Schade D, Ma Y, Fujimoto WY, Barrett‐Connor E, Fowler S, et al. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. The journals of gerontology. Series A, Biological sciences and medical sciences 2006;61(10):1075‐81. [MEDLINE: 17077202]
Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 2002;25(12):2165‐71.
Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program: baseline characteristics of the randomized cohort. Diabetes Care 2000;23:1619‐29.
Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care 1999;22:623‐34.
Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program: recruitment methods and results. Controlled Clinical Trials 2002;23:157‐71.
Knowler WC, Barrett‐Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 2002;346(6):393‐403.
The Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program. Diabetes Care 2003;26:36‐47.
The Diabetes Prevention Program Research Group. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. Diabetes Care 2005;28:888‐94.
The Diabetes Prevention Program Research Group. Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes 2005;54:1566‐72.
The Diabetes Prevention Program Research Group. Within‐trial cost‐effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care 2003;26:2518‐23.

DPS 2001 {published data only}

Eriksson J, Lindström J, Valle T, Aunola S, Hämäläinen H, Ilsnne‐Parikka P, et al. Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1‐year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 1999;42:793‐801.
Lindström J, Ilanne‐Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow‐up of the Finnish Diabetes Prevention Study. Lancet 2006;368:1673‐9.
Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson G, et al. The Finnish Diabetes Prevention Study (DPS). Diabetes Care 2003;26:3230‐6.
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne‐Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. The New England Journal of Medicine 2001;344(18):1343‐50.
Uusitupa M, Lindi V, Louheranta A, Salopuro T, Lindström J, Tuomilehto J. Long term improvement in insulin sensivity by changing lifestyles of people with impaired glucose tolerance; 4‐year results from the Finnish Diabetes Prevention Study. Diabetes 2003;52:2532‐8.
Uusitupa M, Louheranta A, Lindström J, Valle T, Sundvall J, Eriksson J, et al. The Finnish Diabetes Prevention Study. British Journal of Nutrition 2000;83(Supplement 1):S137‐52.

IDPP 2006 {published data only}

Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP‐1). Diabetologia 2006;49:289‐97.
Ramachandran A, Snehalatha C, Yamuna A, Mary S, Ping Z. Cost‐effectiveness of the interventions in the primary prevention of diabetes among Asian Indians. Within‐trial results of the Indian Diabetes Prevention Programme (IDPP). Diabetes Care 2007;30:2548‐52.

Kosaka 2005 {published data only}

Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes research and clinical practice 2005;67:152‐62.

Oldroyd 2005 {published data only}

Oldroyd JC, Unwin NC, White M, Imrie K, MAthers JC, Alberti KGMM. Randomised controlled trial evaluating the effectiveness of behavioural interventions to modify cardiovascular risk factors in men and women with impaired glucose tolerance: outcomes at 6 month. Diabetes Research and Clinical Practice 2001;52:29‐43.
Oldroyd JC, Unwin NC, White M, Mathers JC, Alberti KGMM. Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance. Diabetes Research and Clinical Practice 2006;72:117‐27.

Wing 1998 {published data only}

Wing RR, Venditti E, Jakicic JM, Polley BA, Lang W. Lifestyle intervention in overweight individual with a family history of diabetes. Diabetes Care 1998;21:350‐9.

References to studies excluded from this review

Davey Smith 2005 {published data only}

Davey Smith G, Bracha Y, Svendsen KH, Neaton JD, Haffner SM, Kuller LH. Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial. Annals of internal medicine 2005;142(5):313‐22.

De la Rosa 2007 {published data only}

De la Rosa A, Fogelfeld L, Kolish J, Sanghani R, Pikelny I, Stronger JH. Detecting and managing metabolic syndrome: preliminary results. Ethnicity and Disease 2007;17(S5):24‐5.

Dyson 1997 {published data only}

Dyson PA, Hammersley MS, Morris RJ, Holman RR, Turner RC. The Fasting Hyperglycaemia Study: II. Randomized controlled trial of reinforced healthy‐living advice in subjects With increased but not diabetic fasting plasma glucose. Metabolism 1997;46(12, Suppl 1):50‐5.

Eriksson 1991 {published data only}

Eriksson KF, Lindgarde F. Prevention of type 2 (non‐insulin‐dependent) diabetes mellitus by diet and physical exercise. The 6‐year Malmo feasibility study. Diabetologia 1991;34:891‐8.

Eriksson 2006 {published data only}

Eriksson KM, Westborg CJ, Eliasson MCE. A randomized trial of lifestyle intervention in primary healthcare for the modification of cardiovascular risk factors. The Björknäs study. Scandinavian Journal of Public Health 2006;34:453‐61.

Fang 2004 {published data only}

Fang GJ, Luo GB, Qin ML. Effect of jiangtang bushen recipe in intervention treatment of patients with impaired glucose tolerance. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004;24:317‐20.

Grey 2004 {published data only}

Grey M, Berry D, Davidson M, Galasso P, Gustafson E, Melkus GD. Preliminary testing of a program to prevent type 2 diabetes among high risk youth. The Journal of school health 2004;74(1):10‐5.

Huang 2007 {published data only}

Huang SH, Weng KP, Hsieh KS, Ou SF, Lin CC, Chien KJ, et al. Effects of a classroom‐based weight‐control intervention on cardiovascular disease in elementary‐school obese children. Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi 2007;48:201‐6.

Liao 2002 {published data only}

Carr DB, Utzschneider KM, Boyko EJ, Asberry PJ, Hull RL, Kodama K, et al. A reduced‐fat diet and aerobic exercise in Japanese Americans with impaired glucose tolerance decreases intra‐abdominal fat and improves insulin sensitivity but not beta‐cell function. Diabetes 2005;54(2):340‐7.
Liao D, Asberry PJ, Shofer JB, Callahan H, Matthys C, Boyko EJ, et al. Improvement of BMI, body composition, and body fat distribution with lifestyle modification in Japanese Americans with impaired glucose tolerance. Diabetes Care 2002;25(9):1504‐10.

Lindahl 1999 {published data only}

Lindahl B, Nilsson TK, Jansson JH, Asplund K, Hallmans G. Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance. Journal of Internal Medicine 1999;246:105‐12.

Page 1992 {published data only}

Page RCL, Harnden, Cook JTE, Turner RC. Can life‐styles of subjects with impaired glucose tolerance be changed? A feasibility study. Diabetic Medicine 1992;9:562‐6.

Sakane 2006 {published data only}

Sakane N. Japan Diabetes Prevention Program. Nippon Rinsho 2005;63(Suppl 2):488‐92.

Tao 2004 {published data only}

Tao LL, Deng YB, Fan XB, Bao QD. Effect of exercise training in patients with impaired glucose tolerance. Zhongguo Linchuang Kangfu 2004;8:2912‐3.

Thompson 2008 {published data only}

Thompson JL, Allen P, Helitzer DL, Qualls C, Whyte AN, Wolfe VK, et al. Reducing diabetes risk in American Indian women. American Journal of Preventive Medicine 2008;34(3):192‐201.

Villareal 2006 {published data only}

Villareal DT, Miller III BV, Banks M, Fontana L, Sinacore DR, Klein S. Effect of lifestyle intervention on metabolic coronary heart didease risk factors in obese older adults. American Journal of Clinical Nutrition 2006;84:1317‐23.

References to studies awaiting assessment

Kinmonth 2008 {published data only}

Kinmonth AL, Wareham NJ, Hardeman W, Sutton S, Prevost AT, Fanshawe T, et al. Efficacy of a theory‐based behavioural intervention to increase physical activity in an at‐risk group in primary care (ProActive UK): a randomised trial. Lancet 2008;371:41‐8.

Mensink 2003 {published data only}

Mensink M, Blaak EE, Corpeleijn E, Saris WH, de Bruin TW, Feskens EJ. Lifestyle Intervention According to General Recomendation Improves Glucose Tolerance. Obesity Research 2003;11(12):1588‐96.
Mensink M, Corpeleijn E, Feskens EJM, Kruijshoop M, Saris WHM, de Bruin TWA, et al. Study on lifestyle‐intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results.. Diabetes Research and Clinical Practice 2003;61:49‐58.
Mensink M, Feskens EJM, Saris WHM, de Bruin TWA, Blaak EE. Study on Lifestyle Intervention and impaired Glucose Tolerance Maastricht (SLIM): preliminary results after one year. International Journal of Obesity 2003;27:377‐84.

Savoye 2007 {published data only}

Savoye M, Shaw M, Dziura J, Tamborlane WV, Rose P, Guandalini C, et al. Effects of a weight management program on body composition and metabolic parameters in overweight children. A randomized controlled trial. JAMA: the journal of the American Medical Association 2007;297(24):2697‐704.

EDPS {published data only}

White M, Mathers J, Albeti G. The European Diabetes Prevention Study (EDPS).

ADA 1996

American Diabetes Association. Diabetes 1996: Vital Statistics. Alexandria VA: American Diabetes Association, 1996.

ADA 1997

American Diabetes Association. Report on the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20 Suppl 1:S5‐20.

ADA 1999

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1999;22 Suppl 1:S5‐19.

ADA 2003

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow‐up Report on the Diagnosis of Diabetes Mellitus.. Diabetes Care 2003;26(11):3160‐7.

ADA 2004

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27 Suppl 1:S5‐10.

ADA 2004b

American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2004;27 Suppl 1:S11‐14.

Beck‐Nielsen 2000

Beck‐Nielsen H, Hother‐Nielsen O. Obesity in type 2 diabetes mellitus. In: LeRoith D, Taylor SI, Olefsky JM editor(s). Diabetes Mellitus. A fundamental and clinical text. 2nd Edition. Philadelphia: Lippincott, Williams and Wilkins, 2000:567‐75.

DPP 2002

Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. The New England Journal of Medicine 2002;346(6):393‐403.

DPS 2003

Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, et al. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3‐year results on diet and physical activity. Diabetologia 2003;26(12):3230‐6.

Eriksson 1991

Eriksson KF, Lindgarde F. Prevention of type II (non‐insulin‐dependent) diabetes mellitus by diet and exercise: the 6‐year Malmo feasibility study. Diabetologia 1991;34:891‐8.

Gillies 2007

Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, Khunti K. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta‐analysis. BMJ 2007;334:299. [MEDLINE: 17237299]

Harris 1998

Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, et al. Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in U.S. adults. The third national health and nutrition examination survey, 1988‐1994. Diabetes Care 1998;21(4):518‐24.

Helmrich 1991

Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS. Physical activity and reduced occurrence of non‐insulin‐dependent diabetes mellitus. New England Journal of Medicine 1991;325:147‐52.

Herman 2005

Herman WH, Hoeger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, et al. The Cost‐Effectiveness of lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance. Annals of Internal Medicine 2005;142:323‐332.

Higgins 2002

Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Statistics in medicine 2002;21:1539‐58.

Higgins 2003

Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analysis. BMJ 2003;327:557‐60.

Higgins 2008

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org..

Lau 2006

Lau J, Ioannidis JPA, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ 2006;333:597‐600.

Lillioja 1993

Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, et al. Insulin resistance and insulin secretory dysfunction as precursors of non‐insulin‐dependent diabetes mellitus: prospective studies of Pima Indians. New England Journal of Medicine 1993;329:1988‐92.

Manson 1992

Manson JE, Nathan DM, Krolewski AS, Stampfer MJ, Willett WC, Hennekens CH. A prospective study of exercise and incidence of diabetes among U.S. male physicians. JAMA 1992;268(1):63‐7.

Moher 1999

Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta‐analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta‐analyses. Lancet 1999;354(9193):1896‐900.

Moore 2005

Moore H, Summerbell CD, Hooper L, Ashton V, Kopelman P. Dietary advice for the prevention of type 2 diabetes mellitus in adults. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD005102]

NDDG 1979

National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039‐57.

Norris 2005

SL Norris, X Zhang, A Avenell, E Gregg, CH Schmid, Lau J. Long‐term non‐pharmacological weight loss interventions for adults with prediabetes. Cochrane Database of Systematic Reviews 2005;Issue 2. [DOI: 10.1002/14651858.CD005270]

Rewers 1995

Rewers M, Hamman RF. Risk factors for non‐insulin‐dependent diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH editor(s). Diabetes in America. 2nd Edition. Washington DC: US Govt. Printing Office, 1995:179‐220.

Rosenbloom 1999

Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22(2):345‐54.

Ross 2000

Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, et al. Reduction in obesity and related comorbid conditions after diet‐induced weight loss or exercise‐induced weight loss in men. A randomized, controlled trial. Annals of Internal Medicine 2000;133:92‐103.

Stamler 1999

Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, et al. Low risk‐factor profile and long‐term cardiovascular and noncardiovascular mortality and life expectancy. Findings of 5 large cohorts of young adult and middle‐aged men and women. JAMA 1999;282(21):2012‐8.

Stampfer 2000

Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. New England Journal of Medicine 2000;343:16‐22.

Sterne 2001

Sterne JAC, Egger M, Davey Smith G. Investigating and dealing with publication and other biases. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care; Meta‐analysis in Context. London: BMJ Publishing Group, 2001:189‐208.

WHO 1980

WHO Expert Committee on Diabetes Mellitus. Second report. Technical Report Series 646. Geneva. WHO, 1980.

WHO 1985

WHO Expert Committee on Diabetes Mellitus. World Health Organization, 1985. Technical Report Series 727.

WHO 1994

Report of a World Health Organization Study Group. Prevention of Diabetes Mellitus. WHO Technical Report Series. Vol. 844, Geneva: World Health Organization, 1994.

WHO 1997

Report of a World Health Organization Study Group. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183–1197.

WHO 1998

Alberti KM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its compliactions. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine 1998;15:539‐53.

WHO 1999

World Health Organization: Definition, Diagnosis, Classification of Diabetes Mellitus, Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Report of a World Health Organization Consultation. Geneva: World Health Organization, 1999:1‐59.

Yamaoka 2005

Yamaoka K, Tango T. Efficacy of Lifestyle Education to Prevent Type 2 Diabetes. A meta‐analysis of randomized controlled trials. Diabetes Care 2005;28:2780‐6.

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Bo 2007

Methods

Follow‐up: 1 year.
Number study arms: 2: exercise+diet and control group; number of participants randomised to each group: 187 randomised to I2 and 188 to CG..
Setting: Asti (Northwesten Italy).
Number of study centres: NR.
Language of publication: English.
ITT analysis: N.
Per‐protocol analysis: Y.

Participants

Randomised number: I2:187, CG: 188
Analysed number: I2: 169, CG: 166.
Age (years): I2: 55.7(5.7); C1: 55.7(5.6)

Sex (% female): I2: 58.6; C1: 57.8

Baseline BMI: I2: 29.7(4.1); C1: 29.8(4.6)

Inclusion criteria: age: 45‐64 years
metabolic syndrome or two components of metabolic syndrome plus high‐sensitivity CRP (hs‐CRP) serum values ≥3 mg/L, the cutoff point that differentiates high‐risk groups for future cardiovascular events.

Exclusion criteria: Diseases which require specific diet and exercise recommendations: diabetes, cardiovascular diseases, chronic liver or kidney disease and advanced cancer

Ethnic group: NR.
BL comparable: Yes.

Interventions

Duration of intervention: 1 year.
Intervention groups:
I2: Family physician advice plus detailed verbal and written recommendation including individually prescribed diet and advise on exercise mainly by suggesting moderate‐intensity activity, such as brisk walks for ar least 150 minutes/week. Sessions had a flexible structure, sensitive to cultural differences and patient expectations.
CG: family physician advice emphasizing on the importance of a healthy lifestyle according to their usual clinical practice.
Behavioral intervention: NR.
Frecuency: NR.
No. of contacts: 5.
Group/Individual: Individual.
Medium: In person.
Facilitator: nutritionists, specialists in endocrinology and internal medicine.

Outcomes

Primary outcomes: IDM
Secondary outcomes: IFG, FPG, W, BMI, Waist, TG, HDL, Chol, SBP, DBP,

Notes

Stated aim of study: To know wether a program of moderate intervention might effectively reduce metabolic abnormalities in the general population.

Randomization procedure: performed by using an SAS program stratifying participants according to sex, education level, general practitioner, area of residence, and number of metabolic syndrome components.
Allocation concealment: Yes.
Attrition (%): 11
Blinding assessor: Yes.

Risk of bias

Bias

Authors' judgement

Support for judgement

Adequate sequence generation?

Low risk

Quote: "Participants were stratified according to age, sex, education level..."

"the randomisation procedure was automatically performed by a statistician using a SAS programme developed to minimize the differences between the two groups for all stratifying variables."

Allocation concealment?

Low risk

Quote: "Random allocation with a minimization algorithm was centrally performed in a single step. The researchers then received the two lists of nominative data."

Blinding?
All outcomes

Low risk

Quote: "Because of the nature of the intervention, blinding participants and health professionals was not possible. Family physicians, the physicians who collected data, the dietician, and the laboratory personnel were blinded to the group assignment."

Incomplete outcome data addressed?
All outcomes

Low risk

Quote: "Written informed consent to participate was not given by 18 of 187 (9.6%) and 22 of 188 (11.7%) subjects from the intervention group and the control group, respectively."

Free of selective reporting?

Unclear risk

Comment: Insufficient information provided.

Free of other bias?

Low risk

Da Qing 1997

Methods

Follow‐up: 6 years.
Number study arms: 4: exercise ‐only, exercise+diet, diet‐only and control group; number of participants randomised to each group: NR.
Setting: Chinese community.
Number of study centres: 33 health care clinics.
Language of publication: English.
ITT analysis: trial authors stated: Yes.
Per‐protocol analysis: Yes.

Participants

Randomised number: 577.
Analysed number: I1 141, I2: 126, I3: 130, CG: 133.
Age (years):45.0 (9.1).
Sex (% female): 47.0.
Baseline BMI: 25.8 (3.8).
Inclusion criteria: 2h PG glucose>=120 mg/dl (6.7 mmol/L) and <200 mg/dl (11.0 mmol/L), followed by 2h OGTT (WHO 1985).
Exclusion criteria: NR.
Ethnic group: Asian.
BL comparable: Yes.

Interventions

Duration of intervention: 6 years.
Intervention groups:
I1: encouraged to increase the amount of physical exercise; duration dependent on intensity.
I2: instructions and counseling similar to those for diet only and exercise only intervention groups.
I3: reducing energy intake: diet and diet+exercise groups: if BMI <25, 25‐30 kcal/kg with 55‐65% carbohydrate,10%‐15% protein, 25%‐30% fat; if BMI>25, goal to lose 0.5 to 1.0 kg/month until BMI = 23 kg/m2.
CG: general instructions for diet and/or increased leisure physical activities.
Behavioral intervention: NR.
Frecuency: both diet and exercise interventions: counselling sessions weekly for 1 month, monthly for 3 months, and then once every 3 months.
No. of contacts: 30.
Group/Individual: Both.
Medium: In person.
Facilitator: Physician and team.

Outcomes

Primary outcomes: IDM
Secondary outcomes: FPG, 2h PG, M

Notes

Stated aim of study: to determine whether diet and exercise interventions in those with IGT may delay the development of DM.
Randomization procedure: by clusters, method of randomisation: NR.
Allocation concealment: NR .
Attrition (%):8. Blinding assessor: NR.

Risk of bias

Bias

Authors' judgement

Support for judgement

Adequate sequence generation?

Unclear risk

Quote: "subjects were randomised by clinic"

Allocation concealment?

Unclear risk

Comment: no information

Blinding?
All outcomes

Unclear risk

Comment: no information

Incomplete outcome data addressed?
All outcomes

Unclear risk

Quote: "7 people refused follow‐up, 29 left Da Qing..., and 11 died... No deaths... occurred in the exercise... Three deaths occurred in the control..."

"Those who left in 1988 very early in the study and before the first follow‐up for reasons unrelated to their randomisation group were not included in the analysis. The 11 who died were retained, although none had developed diabetes before death."

Free of selective reporting?

Unclear risk

Comment: insufficient information provided.

Free of other bias?

High risk

Quote: "Physical exercise, expressed in units per day, was significantly higher at baseline in the diet‐plus exercise group than in the control group."

DPP 2002

Methods

Follow‐up: average 2.8 years; range 1.8‐4.6.
Number study arms: 3: lifestyle (exercise+diet),
metformin (not reported here) and control group (standard recommendation+placebo): 1079 randomised to I2 and 1082 to CG.
Setting: USA.
Number of study centres: 27.
Language of publication: English.
ITT analysis: Yes.
Per‐protocol analysis: No.

Participants

Randomised number: 3234
Analysed number: I2: 1079, CG: 1082.
Age (years): 50.6 (10.7).
Sex (% female): 67.7.
Baseline BMI: 34.0 (6.7).
Inclusion criteria: >=25 years, BMI>=24 in Asians BMI>=22, FPG 95‐125 mg/dl (5.3‐6.9 mmol/L) and 2‐h OGTT
140‐199 mg/dl (7.8‐11.0 mmol/L) (ADA 1997).
Exclusion criteria: participants taking medicines known to alter glucose tolerance or if they had illnesses that could seriously reduce their life expectancy or their ability to participate in the trial.
Ethnic group: White (54.7%), African American (19.9%), Hispanic (15.7%), American Indian (5.3%), Asian (4.4%).
BL comparable: Yes.

Interventions

Duration: Average 2.8 years, range 1.8‐4.6
Intervention groups: I2: physical activity intervention: moderate‐intensity exercise for
150 min a week; supervised group exercise sessions twice a week were offered.
Dietary intervention: goal 7% weight loss through a healthy low‐calorie, low‐fat diet.
CG: written information and annual 30 min
individual session on healthy lifestyles.
Behavioral intervention: culturally sensitive materials and motivational strategies.
Frequency: 16 lessons in first 24 weeks, then monthly.
No.of contacts:40
Group/individual: both.
Medium: In person.
Facilitator: Case manager ("lifestyle coach"), usually a dietitian.

Outcomes

Primary outcomes: IDM, CVD
Secondary outcomes: FPG, W, BMI, WHR, Waist, SBP, DBP, Cost

Notes

Stated aim of study: to evaluate whether a lifestyle‐intervention program or the administration of metformin would prevent or delay the development of diabetes.
Randomisation procedure: adaptive randomisation.
Allocation concealment: NR
Attrition (%): 8.
Blinding assessor: Yes.

Risk of bias

Bias

Authors' judgement

Support for judgement

Adequate sequence generation?

Unclear risk

Quote: "adaptative randomisation is stratified by clinical centre"

Allocation concealment?

Low risk

Quote: "The urn method was used"

Blinding?
All outcomes

Low risk

Quote: "Investigators and participants remain masked to primary outcome data until progression to diabetes is confirmed." "Assignments to metformin and placebo were double‐blinded"

Incomplete outcome data addressed?
All outcomes

Low risk

Quote: "Participants who prematurely discontinue their follow‐up visits before confirmed development of diabetes will be censored as of their last follow‐up visit."

Free of selective reporting?

Unclear risk

Comment: Outcomes published in many different publications. Many outcomes are reported incompletely so that they cannot be entered in a meta‐analysis.

Free of other bias?

Low risk

DPS 2001

Methods

Follow‐up: 3.2 years.
Number study arms: 2: exercise plus diet and control group: 265 randomised to I2 and 257 to CG.
Setting: Finland.
Number of study centres: 5.
Language of publication: English.
ITT analysis: stated yes by the trial authors.
Per‐protocol analysis: Yes.

Participants

Randomised number: 522.
Analysed number: I2: 256, CG: 250.
Age (years): 55 (7.0).
Sex (%female): 67.0.
Baseline BMI: 31.1 (4.6)
Inclusion criteria: BMI>=25; IGT (2‐h post prandial plasma glucose 140‐200 mg/dl [7.8‐11.0 mmol/L ]) and FPG <140mg/dl (7.8 mmol/L) (WHO 1985), 40‐65 years.
Exclusion criteria: diagnosis of diabetes mellitus, chronic disease, psychological or physical disabilities deemed likely to interfere with participation in the study.
Ethnic group: NR.
BL comparable: Yes.

Interventions

Duration of intervention: mean 3.2 years.
Intervention group:
I2: Individual counseling regarding moderate activity 30 minutes / day; supervised strength training; frequency and availability varied among study centers.
Dietary intervention:
Low fat, high‐fiber diet; goal BMI <25 or 5‐10kg weight loss; <50%
carbohydrate,<30% fat,<300 mg / day cholesterol.
CG: general written and oral information to prevent DM at baseline and annually.
Behavioral intervention: food records; goal setting.
Frecuency: 7 sessions with dietitian first year, then every 3 months.
No. of contacts: 15.
Group/Individual: individual.
Medium: In person.
Facilitator: physician, nurse, nutritionist, physiotherapist.

Outcomes

Primary outcomes: IDM
Secondary outcomes: FPG, 2h PG, W, BMI, Waist, TG, HDL, Chol, SBP, DBP, Cost,

Notes

Stated aim of study: to assess the efficacy of an intensive diet‐exercise programme in preventing or delaying Type II DM in individuals with IGT.
Randomization procedure: using a list, stratified by center, sex, and 2h PG value.
Allocation concealment: NR .
Attrition (%): 8. Blinding assessor: Yes.

Risk of bias

Bias

Authors' judgement

Support for judgement

Adequate sequence generation?

Unclear risk

Quote: "randomization list, with stratification according to center, sex and mean 2hPG.

Allocation concealment?

High risk

Quote: "randomly assigned to the intervention group or the control group by the study physician, with the use of a randomization list"

Blinding?
All outcomes

Low risk

Quote: "The nurses who scheduled the study visits did not have access to the randomization list... Laboratory staff did not know the subjects' group assignments, and the subjects were not informed of their plasma glucose concentrations during follow‐up unless diabetes was diagnosted."

Incomplete outcome data addressed?
All outcomes

Low risk

Quote: "...were defined as dropouts... data from their earlier visits were included in the analyses."

"40 subjects (8 percent) withdrew ‐ 23 in the intervention group and 17 in the control group... 9 could no tbe contacted, 3 withdrew due to severe ilness, 1 died, and 27 withdrew for personal reasons."

Free of selective reporting?

Unclear risk

Comment: Insufficient information provided.

Free of other bias?

Low risk

IDPP 2006

Methods

Follow‐up: mean 30 months.
Number study arms: 4: exercise+diet defined as lifestyle modification (LSM), metformin group (not reported here), LSM+metformin (not reported here), and control group: 133 randomised to I2 and 136 to CG.
Setting: India.
Number of study centers: NR.
Language of publication: english.
ITT analysis: No.
Per‐protocol analysis: Yes.

Participants

Randomised number: 531.
Analysed number:
I2: 120, I3: 129, I4: 133, CG: 136.
Age (years): 45.9
Sex (%female): 21
Baseline BMI: 25.8
Inclusion criteria: IGT: mean 2‐h post prandial plasma glucose 140‐199 mg/dl [7.8‐11.0 mmol/L] and FPG <126mg/dl (7.0 mmol/L) (WHO 1999).
Exclusion criteria: diagnosis of DM during recruitment.
Ethnic group: Asian Indian.
BL comparable: Yes.

Interventions

Duration of intervention: 3 years.
Intervention groups:
I2: physical activity intervention: participants involved in exercise regularly were to ask to continue their routine activities. Sedentary or light physical activity participants encouraged to physical activity at least 30 min/day.
Dietary intervention: reduction in total calories, refined carbohidrates and fats, inclusion of fiber‐rich foods.
CG: standard health care advice.
Behavioral intervention: motivational strategies.
Frequency: every 6 months.
No.of contacts: 6.
Group/individual: individual.
Medium:In person.
Facilitator: physician dietician and social worker.

Outcomes

Primary outcomes: IDM
Secondary outcomes: FPG, 2h PG, W, BMI, WHR, Chol, HDL, LDL, TG, SBP, DBP, M

Notes

Stated aim of study: tested whether the progression to diabetes could be influenced by interventions in native Asia Indians with IGT.
Randomization procedure: NR.
Allocation concealment: NR .
Attrition (%): 6.
Blinding assessor: the principal investigators were blinded to interim results.

Risk of bias

Bias

Authors' judgement

Support for judgement

Adequate sequence generation?

Unclear risk

Quote: "were consecutively randomised in the four groups"

Allocation concealment?

Unclear risk

Comment: no information

Blinding?
All outcomes

Low risk

Quote: "The principal investigators were blinded to the interim results."

Incomplete outcome data addressed?
All outcomes

Low risk

Comment: Lost to follow‐up and drop outs described in a flow chart.

Free of selective reporting?

Unclear risk

Comment: Insufficient information provided.

Free of other bias?

Low risk

Kosaka 2005

Methods

Follow‐up: 4 years.
Number study arms: 2:
Intensive intervention group (intervention group) and
standard intervention group (control group): 102 randomised to I2 and 356 to CG.
Setting: Japan.
Number of study centers: NR.
Language of publication: english.
ITT analysis: NR.
Per‐protocol analysis: Yes.

Participants

Randomised number: 484.
Analysed number: I2: 102, CG: 356.
Age (years): 51.5 (NR).
Sex (% female): 0.
Baseline BMI: 23.9 (2.2)
Inclusion criteria: FPG<140 mg/dl and a 2‐h PG value between 160 and 239 mg/dl on 100 g OGTTs; the individuals had IGT according to the WHO criteria in 1980.
Exclusion criteria: Known DM, diagnosed or suspected malignant neoplasm, diagnosed or suspected disease of the liver, pancreas, endocrine organs, or kidney; ischemic heart disease or cerebrovascular disease.
Ethnic group: Asian.
BL comparable: Yes.

Interventions

Duration of intervention: 4 years.
Intervention group:
I2: physical activity: walking 30‐40 min/day or 30 min cycling in weekends was recomended.
advised to lose weight if BMI >=22 Kg/m2 by eating smaller meals
(reduce amount about 10%), reduce consume of fat‐rich foods.
CG: advised to lose weight if BMI >=24 Kg/m2 taking 5–10% smaller meals, and to increase their physical activity.
Behavioral intervention: encourage cooperation of the family members, goal setting.
Frequency: every 6 months for controls and 3‐4 months for intervention group.
No.of contacts: 8.
Group/individual: individual.
Medium: In person.
Facilitator: NR.

Outcomes

Primary outcomes:
IDM
Secondary outcomes:
W

Notes

Stated aim of study: to assess the effect of lifestyle intervention on the incidence of diabetes in males with IGT. Randomization procedure: one of every five persons was randomly selected for allocating to the I2, and the others were assigned to the CG.
Allocation concealment: NR .
Attrition (%): 13.
Blinding assessor: NR.

Risk of bias

Bias

Authors' judgement

Support for judgement

Adequate sequence generation?

Unclear risk

Quote: "One of every five subjects was randomly selected for allocation the intensive intervention group, and the others were assigned to the standard intervention (control) group."

Allocation concealment?

Unclear risk

Comment: no information

Blinding?
All outcomes

Unclear risk

Comment: no information

Incomplete outcome data addressed?
All outcomes

Unclear risk

Comment: no reasons for missing data provided.

Free of selective reporting?

Unclear risk

Comment: insufficient information provided.

Free of other bias?

Low risk

Oldroyd 2005

Methods

Follow‐up: 24 months.
Number study arms:2: I2: Live style(exercise+diet), CG: No lifestyle advise: 37 randomised to I2 and 32 randomised to CG.
Setting: UK.
Number of study centres: 1.
Language of publication: English.
ITT analysis: Yes.
Per‐protocol analysis: No.

Participants

Randomised number: 78
Analysed number: I2: 37, CG: 32 at 6 month; I2: 32, CG: 30 at 12 month; I2: 30, CG: 24 at 24 month
Age(years): I2: 58 (41‐75); CG: 57 (41‐73)
Sex(%female): 43
Baseline BMI: I2: 30.4 (5.6); CG: 29.9 (4.9)
Inclusion criteria: IGT (2‐h post glucose load plasma glucose 140‐200 mg/dL [7.8‐11.0 mmol/L]) (WHO 1985);
24‐75 years.
Exclusion criteria: Pregnant individuals, on therapeutic diets or whose medical condition prevent them from undertaking moderate physical activity.
Ethnic group: White.
BL comparable: Yes.

Interventions

Duration: 24 month.
I2: Physical activity intervention: graded plan, tailored to the participants lifestyle and designed to enable them to achieve 20‐30 min of aerobic activity al least once a week. CITY CARD is provided, offering up to 80% discount on use of public leisure facilities.
Diet intervention: Reduce BMI to <25 in overweight; <=30 % of energy from fat; polyunsaturated to saturated fat ratio >=1.0; 50% from carbohydrate; >=20g per 4.2MJ dietary fibre intake.
CG: No intervention.
Behavioral intervention: motivational interviewing to develop an individual action plan for behaviour change.
Frequency: first 6 months 3 appointments at 2 weekly intervals, followed by 3 at monthly intervals. One after 9 months and 5 at 2 monthly intervals between 12 and 24 months.
No. of contacts: 12
Group/Individual: Individual.
Medium: In person.
Facilitator: Dietitian and physiotherapist.

Outcomes

Primary outcomes: IDM
Secondary outcomes: FPG, 2h PG, W, BMI, WHR, Waist, TG, HDL, LDL, Chol, SBP, DBP, M

Notes

Stated aim of study: To evaluate the efficacy of interventions to promote a healthy diet and physical activity in people with impaired glucose tolerance.
Randomization procedure: using a random number table to the intervention or control group.
Allocation concealment: YES (not clear if adequate)
Attrition (%): 31
Blinding assessor: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Adequate sequence generation?

Low risk

Quote: "...using a random number table to the intervention or control group at the first appointment."

Allocation concealment?

Low risk

Quote: "Researchers performing the randomisation were blinded to the group allocation."

Blinding?
All outcomes

Unclear risk

Comment: no information.

Incomplete outcome data addressed?
All outcomes

High risk

Comment: there was a high attrition rate, not balanced between treatment groups. Attrition rate was 23% in the treatment group and 38% in the control group after 24 month of follow‐up.

Free of selective reporting?

Unclear risk

Comment: insufficient information.

Free of other bias?

High risk

Quote: "...a significantly larger proportion of control participants reported engaging in regular physical activity sufficient to get their heart thumping at least once a week compared with intervention participant (53% versus 24%)"

"There were fewer women (10/32 (32%)) than men (22/32 (69%)) in the control group compared with the intervention group..."

Wing 1998

Methods

Follow‐up: 2 years.
Number study arms: 4: exercise, exercise+diet, diet and control group: 37 randomised to I1, 40 to I2, 37 to I3 and 40 to CG.
Setting: USA.
Number of study centres: NR.
Language of publication: English.
ITT analysis: NR
Per‐protocol analysis: Yes.

Participants

Randomised number: 154.
Analysed number: I1: 31, I2: 32, I3: 35, CG: 31, at 2 years.
Age (years):45.7 (4.4).
Sex (% female): 79
Baseline BMI: 35.9 (4.3).
Inclusion criteria: overweight subjects (30–100% of ideal body weight), aged 40–55 years, nondiabetic, and had one or two biological parents with DM.
Exclusion criteria: NR.
Ethnic group: NR.
BL comparable: Yes.

Interventions

Duration of intervention: 2 years.
Intervention groups:
I1: encouraged to increase physical activity (e.g., walking 3 miles on each of 5 days in the week) in biweekly increments of 250 Kcal/week to achieve a goal of 1500 Kcal/week.
I2: instructions and counselling similar to those for diet only and exercise only intervention groups.
I3: reducing energy intake: 800–1,000 kcal/day, 20% of calories as fat, for weeks 1–8 then 1,200–1,500 kcal/day at week 16; both the diet and exercise interventions received behavioral therapy.
CG: general written and oral information to lose weight and exercise on their own.
Behavioral intervention: food records for feedback, individualization, motivational strategies.
Frecuency: I1, I2, I3: weekly for the first 6 months, and then biweekly meetings for 6 months, then two 6‐week refresher courses during year 2.
No. of contacts: 51.
Group/Individual: Group.
Medium: In person.
Facilitator: nutritionist, exercise physiologist, behavior therapist.

Outcomes

Primary outcomes: IDM
Secondary outcomes: FPG, W, BMI, WHR, TG, HDL, LDL, Chol, SBP, DBP

Notes

Stated aim of study: to determine the effectiveness over 2 years of diet, exercise, or the combination of diet + exercise on changes in eating and exercise behavior, body weight, cardiovascular risk factors, and the incidence of diabetes in overweight individuals with a parental history of DM.
Randomization procedure: NR.
Allocation concealment: NR.
Attrition (%): 15% at 6 month, 22% at 1 year and 16% at 2 years.
Blinding assessor: NR.

Risk of bias

Bias

Authors' judgement

Support for judgement

Adequate sequence generation?

Unclear risk

Quote: "...were randomly assigned to one of the four treatment conditions."

Allocation concealment?

Unclear risk

Comment: no information.

Blinding?
All outcomes

Low risk

Quote: "All scoring of the 3‐day records was done blinded to treatment condition and phase"

Incomplete outcome data addressed?
All outcomes

Unclear risk

Comment: no information on reasons for missing data provided.

Free of selective reporting?

Unclear risk

Comment: insufficient information provided.

Free of other bias?

Low risk

FPG: fasting plasma glucose, IFG: impaired fasting glucose, IGT: impaired glucose tolerance, 2h PG: 2h plasma glucose, 2h OGTT: 2h 75‐g after oral glucose tolerance test, I1: exercise group, I2: exercise+diet group, I3: diet group, CG: Control Group, DM: Type II diabetes mellitus, IDM: incidence of diabetes mellitus, DCM: diabetes and cardiovascular related morbidity, CHD: coronary heart disease, TG: triglycerides, HDL: HDL‐cholesterol, LDL: LDL‐cholesterol, Chol: total cholesterol, W: weight, BMI: body mass index, WHR: waist‐to‐hip‐ratio, SBP: systolic blood pressure, DBP: diastolic blood pressure, QL: quality of life, AE: adverse effects, M: mortality, BL: base line, AHA: American Heart Association, NR: not reported.

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Davey Smith 2005

Principal findings are based on a post‐hoc sub‐group analysis.
Compared the incidence of diabetes in the intervention and control groups of 'The Multiple Risk Factor Intervention Trial', reported on an unexpected subgroup finding related to baseline cigarette smoking status.

De la Rosa 2007

Not a randomised trial.

Dyson 1997

None of the primary or secondary objectives assessed the incidence of diabetes.

Eriksson 1991

Inadequate randomisation, the control group was not randomised.

Eriksson 2006

Included diabetic participants at baseline.

Fang 2004

Not a randomised controlled trial.

Grey 2004

Both experimental and control groups received the same nutritional education and physical activity training.

Huang 2007

Follow‐up time was less than six months.

Liao 2002

The control group received an intervention that differed to the standard recommendation.

Lindahl 1999

Non of the primary or secondary objectives assessed the incidence of diabetes.

Page 1992

Non of the primary or secondary objectives was to asses the incidence of diabetes.

Sakane 2006

Not a randomised controlled trial.

Tao 2004

Inadequate randomisation: quasi‐randomised patients.

Thompson 2008

Duration of intervention less than six months.

Villareal 2006

None of the primary or secondary objectives assessed the incidence of diabetes.

Characteristics of studies awaiting assessment [ordered by study ID]

Kinmonth 2008

Methods

Randomised controlled trial

Participants

365 sedentary adults who had a parental history of type 2 diabetes.

Interventions

Intervention 1: behavioural change programme delivered by a facilitator over the telephone(distance).

Intervention 2: same programme, but delivered in the home (face to face).

Control: comparison group (advice).

Participants in the two intervention groups were taught to maximise personal advantages and opportunities,and to minimise disadvantages and obstacles to becoming more physically active.

Outcomes

Maximal cardiorespiratory fitness(VO2max), and self‐reported physical activity, Weight, ;body‐fat percentage; and blood pressure, glycosylated haemoglobin, fasting plasma glucose, lipids, and insulin.

Notes

Diabetes incidence was not reported, might be included in further updates.

Mensink 2003

Methods

Randomised controlled trial.

Participants

102 participants with mean 2‐h glucose concentration of two OGTTs of 7.8‐12.5 mmol/L and FPG <7.8 mmol/L.

Interventions

Intervention group: dietary and exercise intervention.

Control group: general information.

Outcomes

change in glucose tolerance (2‐h PG), FPG, plasma insulin concentration, insulin resistance, glycated haemoglobin, and changes in body weight, body composition and VO2max. CHanges in cardiovascular risk factors are assessed (blood pressure and blood lipid profile).

Notes

Final 3 year results not published.

Savoye 2007

Methods

Randomised controlled trial.

Participants

209 overweight children, ages 8‐16 years.

Interventions

Intervention group: weight management intervention: intensive family‐based program including exercise, nutrition, and behaviour modification.

Control group: diet and exercise counseling.

Outcomes

Changes in weight, BMI, body fat, and homeostasis model assessment of insulin resistance, blood pressure, FPG, lipid profile.

Notes

Incidence of diabetes part of a paper that the authors are preparing for publication.

Characteristics of ongoing studies [ordered by study ID]

EDPS

Trial name or title

The European Diabetes Prevention Study (EDPS)

Methods

Multicentre, parallel design, randomised controlled study.

Participants

104 people aged 40 to 75, with IGT and overweight.

Interventions

Intervention group: regular and intensive diet and physical activity advice complemented by a number of small group educational activities.

Control group: will receive routinely available lifestyle advice

Outcomes

The primary outcome measure will be incidence of Type 2 diabetes.
Secondary outcomes: The proportion of energy consumed from fat, protein, carbohydrates and saturated, monounsaturated, polyunsaturated fatty acids, fibre and cholesterol, physical activity, glucose tolerance, insulin sensitivity, cardiovascular risk factors, cardiovascular morbidity and mortality, quality of life.

Starting date

20/07/2000

Contact information

University of Newcastle upon Tyne

Public Health Research Group

Faculty of Medical Sciences

School of Population and Health Sciences

Newcastle upon Tyne

NE2 4HH

United Kingdom

Tel: +44 (0)191 222 6275

Fax: +44 (0)191 222 6461

Email: [email protected]

Notes

Data and analyses

Open in table viewer
Comparison 1. Exercise+diet vs standard recommendations (overall analysis)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Diabetes incidence ‐ ITT (RR/HR) Show forest plot

8

risk/hazard ratio (Random, 95% CI)

0.63 [0.49, 0.79]

Analysis 1.1

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 1 Diabetes incidence ‐ ITT (RR/HR).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 1 Diabetes incidence ‐ ITT (RR/HR).

2 Diabetes incidence ‐ ITT (OR/HR) Show forest plot

8

odds/hazard ratio (Random, 95% CI)

0.51 [0.40, 0.65]

Analysis 1.2

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 2 Diabetes incidence ‐ ITT (OR/HR).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 2 Diabetes incidence ‐ ITT (OR/HR).

3 Mean differences between groups in fasting plasma glucose (mmol/L) Show forest plot

6

3315

Mean Difference (IV, Random, 95% CI)

‐0.19 [‐0.32, ‐0.05]

Analysis 1.3

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 3 Mean differences between groups in fasting plasma glucose (mmol/L).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 3 Mean differences between groups in fasting plasma glucose (mmol/L).

4 Mean differences between groups in 2‐h plasma glucose (mmol/L) Show forest plot

3

756

Mean Difference (IV, Random, 95% CI)

‐0.23 [‐1.08, 0.61]

Analysis 1.4

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 4 Mean differences between groups in 2‐h plasma glucose (mmol/L).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 4 Mean differences between groups in 2‐h plasma glucose (mmol/L).

5 Mean differences between groups in body mass index (BMI ‐ kg/m2) Show forest plot

6

3315

Mean Difference (IV, Random, 95% CI)

‐1.11 [‐2.01, ‐0.21]

Analysis 1.5

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 5 Mean differences between groups in body mass index (BMI ‐ kg/m2).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 5 Mean differences between groups in body mass index (BMI ‐ kg/m2).

6 Mean differences between groups in weight (kg) Show forest plot

7

3773

Mean Difference (IV, Random, 95% CI)

‐2.72 [‐4.72, ‐0.72]

Analysis 1.6

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 6 Mean differences between groups in weight (kg).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 6 Mean differences between groups in weight (kg).

7 Mean differences between groups in waist‐to‐hip ratio (WHR) Show forest plot

4

2546

Mean Difference (IV, Random, 95% CI)

‐0.01 [‐0.02, 0.01]

Analysis 1.7

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 7 Mean differences between groups in waist‐to‐hip ratio (WHR).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 7 Mean differences between groups in waist‐to‐hip ratio (WHR).

8 Mean differences between groups in waist circumference (cm) Show forest plot

4

2983

Mean Difference (IV, Random, 95% CI)

‐3.90 [‐5.90, ‐1.91]

Analysis 1.8

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 8 Mean differences between groups in waist circumference (cm).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 8 Mean differences between groups in waist circumference (cm).

9 Mean differences between groups in total cholesterol (mmol/L) Show forest plot

5

1154

Mean Difference (IV, Random, 95% CI)

‐0.09 [‐0.19, 0.01]

Analysis 1.9

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 9 Mean differences between groups in total cholesterol (mmol/L).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 9 Mean differences between groups in total cholesterol (mmol/L).

10 Mean differences between groups in HDL cholesterol (mmol/L) Show forest plot

5

1154

Mean Difference (IV, Random, 95% CI)

0.04 [‐0.00, 0.09]

Analysis 1.10

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 10 Mean differences between groups in HDL cholesterol (mmol/L).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 10 Mean differences between groups in HDL cholesterol (mmol/L).

11 Mean differences between groups in LDL cholesterol (mmol/L) Show forest plot

3

385

Mean Difference (IV, Random, 95% CI)

0.03 [‐0.11, 0.17]

Analysis 1.11

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 11 Mean differences between groups in LDL cholesterol (mmol/L).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 11 Mean differences between groups in LDL cholesterol (mmol/L).

12 Mean differences between groups in triglycerides (mmol/L) Show forest plot

4

1091

Mean Difference (IV, Random, 95% CI)

‐0.14 [‐0.22, ‐0.05]

Analysis 1.12

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 12 Mean differences between groups in triglycerides (mmol/L).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 12 Mean differences between groups in triglycerides (mmol/L).

13 Mean differences between groups in systolic blood pressure (mmHg) Show forest plot

5

2268

Mean Difference (IV, Random, 95% CI)

‐3.54 [‐4.83, ‐2.24]

Analysis 1.13

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 13 Mean differences between groups in systolic blood pressure (mmHg).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 13 Mean differences between groups in systolic blood pressure (mmHg).

14 Mean differences between groups in diastolic blood pressure (mmHg) Show forest plot

6

2521

Mean Difference (IV, Random, 95% CI)

‐1.79 [‐2.45, ‐1.14]

Analysis 1.14

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 14 Mean differences between groups in diastolic blood pressure (mmHg).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 14 Mean differences between groups in diastolic blood pressure (mmHg).

Open in table viewer
Comparison 2. Exercise vs standard recommendations (overall analysis)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Diabetes incidence ‐ ITT (RR/HR) Show forest plot

2

risk/hazard ratio (Random, 95% CI)

0.69 [0.29, 1.65]

Analysis 2.1

Comparison 2 Exercise vs standard recommendations (overall analysis), Outcome 1 Diabetes incidence ‐ ITT (RR/HR).

Comparison 2 Exercise vs standard recommendations (overall analysis), Outcome 1 Diabetes incidence ‐ ITT (RR/HR).

2 Diabetes incidence ‐ ITT (OR/HR) Show forest plot

2

odds/hazard ratio (Random, 95% CI)

0.67 [0.29, 1.57]

Analysis 2.2

Comparison 2 Exercise vs standard recommendations (overall analysis), Outcome 2 Diabetes incidence ‐ ITT (OR/HR).

Comparison 2 Exercise vs standard recommendations (overall analysis), Outcome 2 Diabetes incidence ‐ ITT (OR/HR).

Open in table viewer
Comparison 3. Exercise vs diet (overall analysis)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Diabetes incidence ‐ ITT (RR/HR) Show forest plot

2

risk/hazard ratio (Random, 95% CI)

0.69 [0.37, 1.29]

Analysis 3.1

Comparison 3 Exercise vs diet (overall analysis), Outcome 1 Diabetes incidence ‐ ITT (RR/HR).

Comparison 3 Exercise vs diet (overall analysis), Outcome 1 Diabetes incidence ‐ ITT (RR/HR).

2 Diabetes incidence ‐ ITT (OR/HR) Show forest plot

2

odds/hazard ratio (Random, 95% CI)

0.65 [0.29, 1.44]

Analysis 3.2

Comparison 3 Exercise vs diet (overall analysis), Outcome 2 Diabetes incidence ‐ ITT (OR/HR).

Comparison 3 Exercise vs diet (overall analysis), Outcome 2 Diabetes incidence ‐ ITT (OR/HR).

QUOROM (quality of reporting of meta‐analyses) flow‐chart of study selection.
Figuras y tablas -
Figure 1

QUOROM (quality of reporting of meta‐analyses) flow‐chart of study selection.

Risk of bias summary: review authors' judgments about each risk of bias item for each included study.
Figuras y tablas -
Figure 2

Risk of bias summary: review authors' judgments about each risk of bias item for each included study.

Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies.
Figuras y tablas -
Figure 3

Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies.

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 1 Diabetes incidence ‐ ITT (RR/HR).
Figuras y tablas -
Analysis 1.1

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 1 Diabetes incidence ‐ ITT (RR/HR).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 2 Diabetes incidence ‐ ITT (OR/HR).
Figuras y tablas -
Analysis 1.2

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 2 Diabetes incidence ‐ ITT (OR/HR).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 3 Mean differences between groups in fasting plasma glucose (mmol/L).
Figuras y tablas -
Analysis 1.3

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 3 Mean differences between groups in fasting plasma glucose (mmol/L).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 4 Mean differences between groups in 2‐h plasma glucose (mmol/L).
Figuras y tablas -
Analysis 1.4

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 4 Mean differences between groups in 2‐h plasma glucose (mmol/L).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 5 Mean differences between groups in body mass index (BMI ‐ kg/m2).
Figuras y tablas -
Analysis 1.5

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 5 Mean differences between groups in body mass index (BMI ‐ kg/m2).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 6 Mean differences between groups in weight (kg).
Figuras y tablas -
Analysis 1.6

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 6 Mean differences between groups in weight (kg).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 7 Mean differences between groups in waist‐to‐hip ratio (WHR).
Figuras y tablas -
Analysis 1.7

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 7 Mean differences between groups in waist‐to‐hip ratio (WHR).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 8 Mean differences between groups in waist circumference (cm).
Figuras y tablas -
Analysis 1.8

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 8 Mean differences between groups in waist circumference (cm).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 9 Mean differences between groups in total cholesterol (mmol/L).
Figuras y tablas -
Analysis 1.9

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 9 Mean differences between groups in total cholesterol (mmol/L).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 10 Mean differences between groups in HDL cholesterol (mmol/L).
Figuras y tablas -
Analysis 1.10

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 10 Mean differences between groups in HDL cholesterol (mmol/L).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 11 Mean differences between groups in LDL cholesterol (mmol/L).
Figuras y tablas -
Analysis 1.11

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 11 Mean differences between groups in LDL cholesterol (mmol/L).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 12 Mean differences between groups in triglycerides (mmol/L).
Figuras y tablas -
Analysis 1.12

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 12 Mean differences between groups in triglycerides (mmol/L).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 13 Mean differences between groups in systolic blood pressure (mmHg).
Figuras y tablas -
Analysis 1.13

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 13 Mean differences between groups in systolic blood pressure (mmHg).

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 14 Mean differences between groups in diastolic blood pressure (mmHg).
Figuras y tablas -
Analysis 1.14

Comparison 1 Exercise+diet vs standard recommendations (overall analysis), Outcome 14 Mean differences between groups in diastolic blood pressure (mmHg).

Comparison 2 Exercise vs standard recommendations (overall analysis), Outcome 1 Diabetes incidence ‐ ITT (RR/HR).
Figuras y tablas -
Analysis 2.1

Comparison 2 Exercise vs standard recommendations (overall analysis), Outcome 1 Diabetes incidence ‐ ITT (RR/HR).

Comparison 2 Exercise vs standard recommendations (overall analysis), Outcome 2 Diabetes incidence ‐ ITT (OR/HR).
Figuras y tablas -
Analysis 2.2

Comparison 2 Exercise vs standard recommendations (overall analysis), Outcome 2 Diabetes incidence ‐ ITT (OR/HR).

Comparison 3 Exercise vs diet (overall analysis), Outcome 1 Diabetes incidence ‐ ITT (RR/HR).
Figuras y tablas -
Analysis 3.1

Comparison 3 Exercise vs diet (overall analysis), Outcome 1 Diabetes incidence ‐ ITT (RR/HR).

Comparison 3 Exercise vs diet (overall analysis), Outcome 2 Diabetes incidence ‐ ITT (OR/HR).
Figuras y tablas -
Analysis 3.2

Comparison 3 Exercise vs diet (overall analysis), Outcome 2 Diabetes incidence ‐ ITT (OR/HR).

Table 1. Summary of main study characteristics

Risk/hazard ratio

IV, Random, 95% CI

Duration of intervention

Inclusion criteria

Diabetes diagnostic criteria

Compliance measure

Wing 1998

2.00 [0.54, 7.43]

2 years

‐ Age 40‐50 years

‐ Overweight (30‐100% of ideal body weight)

‐ 1 or 2 biological parents with type 2 diabetes.

FPG >7.78; 5 additional diabetes cases were found; when using new diagnostic criteria:

FPG >7.0

Exercise: Paffenbarger Physical Activity Questionaire and half‐mile walk test (time to completion) VO2max predicted using regression formulas.

Diet: Black Food Frequency measure (6 month interval) and three day food diaries. 

Oldroyd 2005

0.80 [0.35, 1.82]

2 years

‐ Age 24‐75 years

‐ IGT (1985):

2hPG ≥7.8 mmol/L <11.1 mmol/L

FPG ≥7.8 mmol/L or

2hPG ≥11.1 mmol/L

Exercise: Resting pulse, shuttle walking test and self reported physical activity.

DPS 2001

0.74 [0.54, 1.01]

Mean 3.2 years

‐ Age 40‐64 years

‐ BMI >25 Kg/m2

‐ IGT (WHO 1985)

2hPG: 7.8‐11.0 mmol/L

FPG <7.8 mmol/L

WHO 1985

 

Monitored by individual interviews at each linial visit.

Three day food records.

IDPP 2006

0.74 [0.57, 0.96]

3 years

‐ IGT (WHO 1999)

2hPG= 7.8‐11.0 mmol/L (140‐199 mg/dl)

FPG <7.0 mmol/L (<126 mg/dl)

WHO 1999:

FPG ≥7.0 mmol/L (≥26 mg/dl)

2hPG ≥11.1 mmol/L (≥200 mg/dl)

Adherence self reported, based on weekly pattern.

Da Qing 1997

0.61 [0.38, 0.98]

6 years

‐ IGT (WHO 1985):

2hPG ≥120 mg/dl and <200 mg/dl

FPG ≥140 mg/dl (≥7.8 mmol/L) or

2hPG ≥200 mg/dl (≥11.1 mmol/L)

Exercise and diet: quantified using standardized forms and interviews.

Three day food record.

DPP 2002

0.50 [0.42, 0.59]

Mean 2.8 years

‐ Age ≥25y

‐ BMI ≥24 (=22 in asians)

‐ FPG: 95‐125 mg/dl (5.3‐6.9 mmol/L)

2hPG: 140‐199 mg/dl (7.8‐11.0 mmol/l)

ADA 1997

ADA 1997:

FPG ≥126 mg/dl (≥7.0 mmol/L) or

2hPG ≥200 mg/dl (≥11.1 mmol/L)

Measuring % of participants achieveing the goal of weight loss of 7%.

Physical activity: assessed on the basis of logs kept by the participants.

Kosaka 2005

0.30 [0.09, 0.98]

4 years

‐ IGT (WHO 1980)

FPG <140mg/dl

2hPG (100g OGTT): 160‐239 mg/dl ≈ 140‐199 mg/dl on 75g OGTT

FPG ≥140 mg/dl

 Changes in body weight and achievement of desirable body weight.

Bo 2007

0.29 [0.10, 0.85]

1 year

‐ Age 45‐64 years

‐ Metabolic Syndrome

WHO 1985

Evaluating questionnaires and meeting attendance:

‐ Validated semiquantitative food frequency questionnaire.

‐ Minnesota‐Leisure‐Time‐Physical‐Activity questionnaire.

IGT: Impaired glucose tolerance; FPG: Fasting plasma glucose; 2hPG: 2 hours plasma glucose; OGTT: Oral glucose tolerance test; BMI: Body mass index

Figuras y tablas -
Table 1. Summary of main study characteristics
Table 2. Study populations

Study ID

[n] randomised

[n] safety

[n] ITT

[n] finished study

comments

Bo 2007

375

335

335

335

Da Qing

577

541

530

530

Randomised numbers in each group not specified. Safety population reflects participants who were followed‐up + deaths

DPP 2002

3234

3234

3234

2979

DPS 2001

523

NR

475

475

Authors state that ITT analysis was performed but data are presented as a per protocol analysis

IDPP 2006

531

531

502

502

Kosaka 2005

484

NR

458

458

ITT performed after the first year

Oldroyd 2005

78

77

54

54

Authors state that ITT analysis was performed but data are presented as a per protocol analysis

Wing 1998

154

NR

129

129

Analyses were completed only on the participants who attended the specific assessment

ITT: intention‐to‐treat; NR: not reported

Figuras y tablas -
Table 2. Study populations
Comparison 1. Exercise+diet vs standard recommendations (overall analysis)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Diabetes incidence ‐ ITT (RR/HR) Show forest plot

8

risk/hazard ratio (Random, 95% CI)

0.63 [0.49, 0.79]

2 Diabetes incidence ‐ ITT (OR/HR) Show forest plot

8

odds/hazard ratio (Random, 95% CI)

0.51 [0.40, 0.65]

3 Mean differences between groups in fasting plasma glucose (mmol/L) Show forest plot

6

3315

Mean Difference (IV, Random, 95% CI)

‐0.19 [‐0.32, ‐0.05]

4 Mean differences between groups in 2‐h plasma glucose (mmol/L) Show forest plot

3

756

Mean Difference (IV, Random, 95% CI)

‐0.23 [‐1.08, 0.61]

5 Mean differences between groups in body mass index (BMI ‐ kg/m2) Show forest plot

6

3315

Mean Difference (IV, Random, 95% CI)

‐1.11 [‐2.01, ‐0.21]

6 Mean differences between groups in weight (kg) Show forest plot

7

3773

Mean Difference (IV, Random, 95% CI)

‐2.72 [‐4.72, ‐0.72]

7 Mean differences between groups in waist‐to‐hip ratio (WHR) Show forest plot

4

2546

Mean Difference (IV, Random, 95% CI)

‐0.01 [‐0.02, 0.01]

8 Mean differences between groups in waist circumference (cm) Show forest plot

4

2983

Mean Difference (IV, Random, 95% CI)

‐3.90 [‐5.90, ‐1.91]

9 Mean differences between groups in total cholesterol (mmol/L) Show forest plot

5

1154

Mean Difference (IV, Random, 95% CI)

‐0.09 [‐0.19, 0.01]

10 Mean differences between groups in HDL cholesterol (mmol/L) Show forest plot

5

1154

Mean Difference (IV, Random, 95% CI)

0.04 [‐0.00, 0.09]

11 Mean differences between groups in LDL cholesterol (mmol/L) Show forest plot

3

385

Mean Difference (IV, Random, 95% CI)

0.03 [‐0.11, 0.17]

12 Mean differences between groups in triglycerides (mmol/L) Show forest plot

4

1091

Mean Difference (IV, Random, 95% CI)

‐0.14 [‐0.22, ‐0.05]

13 Mean differences between groups in systolic blood pressure (mmHg) Show forest plot

5

2268

Mean Difference (IV, Random, 95% CI)

‐3.54 [‐4.83, ‐2.24]

14 Mean differences between groups in diastolic blood pressure (mmHg) Show forest plot

6

2521

Mean Difference (IV, Random, 95% CI)

‐1.79 [‐2.45, ‐1.14]

Figuras y tablas -
Comparison 1. Exercise+diet vs standard recommendations (overall analysis)
Comparison 2. Exercise vs standard recommendations (overall analysis)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Diabetes incidence ‐ ITT (RR/HR) Show forest plot

2

risk/hazard ratio (Random, 95% CI)

0.69 [0.29, 1.65]

2 Diabetes incidence ‐ ITT (OR/HR) Show forest plot

2

odds/hazard ratio (Random, 95% CI)

0.67 [0.29, 1.57]

Figuras y tablas -
Comparison 2. Exercise vs standard recommendations (overall analysis)
Comparison 3. Exercise vs diet (overall analysis)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Diabetes incidence ‐ ITT (RR/HR) Show forest plot

2

risk/hazard ratio (Random, 95% CI)

0.69 [0.37, 1.29]

2 Diabetes incidence ‐ ITT (OR/HR) Show forest plot

2

odds/hazard ratio (Random, 95% CI)

0.65 [0.29, 1.44]

Figuras y tablas -
Comparison 3. Exercise vs diet (overall analysis)